NEW YORK ( TheStreet) -- InfoSpace (Nasdaq: INSP) hit a new 52-week high Tuesday as it is currently trading at $12.07, above its previous 52-week high of $11.95 with 24,079 shares traded as of 9:38 a.m. ET. Average volume has been 269,400 shares over the past 30 days.

InfoSpace has a market cap of $462.9 million and is part of the technology sector and internet industry. Shares are up 6.8% year to date as of the close of trading on Friday.

InfoSpace, Inc. develops search tools and technologies that assist consumers with finding information, merchants, individuals, products, and other content on the Internet. It operates in two segments, Core and E-Commerce. The company has a P/E ratio of 27.3, below the average internet industry P/E ratio of 36.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates InfoSpace as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full InfoSpace Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

John Bogle, Founder of Vanguard and Creator of Index Fund, Dies at 89

John Bogle, Founder of Vanguard and Creator of Index Fund, Dies at 89

Government Shutdown Creating Information Blackout for Economists, Policymakers

Government Shutdown Creating Information Blackout for Economists, Policymakers

Eddie Lampert Wins Approval for $5.2 Billion Deal to Save Sears from Liquidation

Eddie Lampert Wins Approval for $5.2 Billion Deal to Save Sears from Liquidation

Real Goods Solar Plows Ahead With Energy Plans

Real Goods Solar Plows Ahead With Energy Plans

3 Things to Know at Market Close: Goldman Sachs, PAX Labs, and CBD

3 Things to Know at Market Close: Goldman Sachs, PAX Labs, and CBD